Zynex (ZYXI) Competitors $2.24 -0.06 (-2.61%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.24 0.00 (0.00%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. SKIN, ZIMV, BSGM, SNWV, DRTS, NYXH, SMTI, CATX, BWAY, and TCMDShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), Perspective Therapeutics (CATX), Brainsway (BWAY), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Zynex vs. Its Competitors Beauty Health ZimVie Biosig Technologies Sanuwave Health Alpha Tau Medical Nyxoah Sanara MedTech Perspective Therapeutics Brainsway Tactile Systems Technology Beauty Health (NASDAQ:SKIN) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Which has stronger earnings & valuation, SKIN or ZYXI? Zynex has lower revenue, but higher earnings than Beauty Health. Zynex is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$334.30M0.72-$29.10M-$0.41-4.66Zynex$192.35M0.35$2.99M-$0.24-9.33 Do institutionals and insiders have more ownership in SKIN or ZYXI? 93.3% of Beauty Health shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer SKIN or ZYXI? In the previous week, Beauty Health had 9 more articles in the media than Zynex. MarketBeat recorded 13 mentions for Beauty Health and 4 mentions for Zynex. Beauty Health's average media sentiment score of 1.06 beat Zynex's score of 0.38 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 4 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zynex 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is SKIN or ZYXI more profitable? Zynex has a net margin of -4.30% compared to Beauty Health's net margin of -11.94%. Zynex's return on equity of -23.70% beat Beauty Health's return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-11.94% -67.91% -5.56% Zynex -4.30%-23.70%-6.23% Do analysts rate SKIN or ZYXI? Beauty Health currently has a consensus target price of $1.42, suggesting a potential downside of 25.83%. Zynex has a consensus target price of $6.00, suggesting a potential upside of 167.86%. Given Zynex's stronger consensus rating and higher probable upside, analysts plainly believe Zynex is more favorable than Beauty Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk & volatility, SKIN or ZYXI? Beauty Health has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. SummaryBeauty Health and Zynex tied by winning 8 of the 16 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$69.55M$10.60B$5.60B$9.11BDividend YieldN/A2.07%5.24%4.02%P/E Ratio-9.3316.2727.9620.25Price / Sales0.3530.15430.5799.61Price / Cash9.4222.9637.4658.16Price / Book2.003.668.045.49Net Income$2.99M$235.43M$3.18B$250.27M7 Day Performance-4.68%1.27%3.63%4.75%1 Month Performance8.21%2.95%4.04%7.64%1 Year Performance-76.27%-15.74%29.56%16.34% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex2.0697 of 5 stars$2.24-2.6%$6.00+167.9%-76.1%$69.55M$192.35M-9.33770News CoverageSKINBeauty Health0.2539 of 5 stars$2.20-3.5%$1.42-35.6%+3.8%$287.27M$334.30M0.001,030Positive NewsZIMVZimVie2.015 of 5 stars$9.43-8.0%$16.33+73.2%-51.9%$285.43M$449.75M12.981,770BSGMBiosig Technologies1.9506 of 5 stars$11.55+11.0%$10.00-13.4%+1,119.7%$284.14M$40K0.0050Gap UpHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$32.63M0.0040DRTSAlpha Tau Medical3.1639 of 5 stars$3.29+3.8%$8.00+143.2%+39.1%$268.88MN/A0.0080Gap UpNYXHNyxoah2.5255 of 5 stars$7.86+1.2%$14.50+84.5%-11.7%$264.65M$4.89M0.00110SMTISanara MedTech2.1703 of 5 stars$29.17-1.6%$49.50+69.7%+0.9%$263.52M$86.67M0.0060Positive NewsHigh Trading VolumeCATXPerspective Therapeutics1.0471 of 5 stars$3.48-5.4%$12.56+260.8%-66.7%$258.31MN/A0.0070BWAYBrainsway2.6735 of 5 stars$13.37+1.0%$14.25+6.6%+91.4%$250.17M$41.02M66.20120Gap UpTCMDTactile Systems Technology3.7566 of 5 stars$9.87-2.6%$16.00+62.1%-15.6%$235.51M$292.98M14.271,037News Coverage Related Companies and Tools Related Companies Beauty Health Alternatives ZimVie Alternatives Biosig Technologies Alternatives Sanuwave Health Alternatives Alpha Tau Medical Alternatives Nyxoah Alternatives Sanara MedTech Alternatives Perspective Therapeutics Alternatives Brainsway Alternatives Tactile Systems Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZYXI Stock Alerts